Comparable stake leader
William Resides
SEC ownership of BIOREGENX, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001593184.
Disclosed value leader
—
Comparable rows
0/10
Latest evidence
08 Mar 2024
- Public ticker
- BRGX on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
William Resides
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
08 Mar 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001593184
- Issuer location
- Chattanooga, TN
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BIOREGENX, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
William Resides
Disclosed value leader
—
Comparable rows
0/10
Latest evidence
08 Mar 2024
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
10 rows are not safely comparable across share classes.
Showing 1-8 of 10 holder rows.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens William Resides's linked filing trail.
Detailed SEC evidence table Showing 1-8 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| William Resides |
3/4/5
CEO, Interim CFO, Director, 10%+ Owner
|
—
mixed-class rows
|
—
218,540,064 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Wilshire Holdings Trust |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
197,865,952 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Joseph S. Bird Jr. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
92,271,744 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Suzanne Bird |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
—
85,215,696 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Libertas Trust |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
84,799,696 shares
mixed-class rows
|
— | 08 Mar 2024 |
| JARA Trust |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
73,840,700 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Robert Doran |
3/4/5
Executive Vice President, Director, 10%+ Owner
|
—
mixed-class rows
|
—
73,840,700 shares
mixed-class rows
|
— | 08 Mar 2024 |
| Gary Hennerberg |
3/4/5
Secretary, Director
|
—
mixed-class rows
|
—
16,436,108 shares
mixed-class rows
|
— | 08 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to BIOREGENX, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Richard Janney
Net 12M change
$0
Latest report
07 Oct 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Richard Janney | Director | Mixed | 07 Oct 2024 | |||
| William Resides | CEO, Interim CFO, Director, 10%+ Owner | Mixed | 08 Mar 2024 | |||
| Jody M. Walker | Director | Mixed | 08 Mar 2024 | |||
| Gary Kiss | Director | Mixed | 08 Mar 2024 | |||
| Suzanne Bird | Director, 10%+ Owner | Mixed | 08 Mar 2024 | |||
| Joseph S. Bird Jr. | 10%+ Owner | Mixed | 08 Mar 2024 | |||
| Sherri Adams | Chief Operating Officer, Director | Mixed | 08 Mar 2024 | |||
| Robert Doran | Executive Vice President, Director, 10%+ Owner | Mixed | 08 Mar 2024 | |||
| Gary Hennerberg | Secretary, Director | Mixed | 08 Mar 2024 | |||
| Libertas Trust | 10%+ Owner | Mixed | 08 Mar 2024 | |||
| JARA Trust | 10%+ Owner | Mixed | 08 Mar 2024 | |||
| Wilshire Holdings Trust | 10%+ Owner | Mixed | 08 Mar 2024 |
Recent insider transactions for BIOREGENX, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.